Powers has this Plymouth-based med-tech startup off to a fast start. That’s partly because Reprise isn’t exactly a startup. This summer, Eden Prairie-based Miromatrix Medical spun off the company, which is marketing two Miromatrix-developed products that have already earned FDA clearance. Called Miromesh and Miroderm, they’re designed to reinforce and repair damaged human tissue. In July, Reprise completed a $12.5 million private placement deal, which should boost sales far beyond the $1.75 million they netted last year. In Powers, a former SVP at Maple Grove-based Vascular Solutions (now part of Pennsylvania firm Teleflex), Reprise has an experienced med-tech marketer at the helm.